Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (INSP)

CUSIP: 457730109

Q2 2019 13F Holders as of 30 Jun 2019

Holder snapshot 7 signals
Share change
+2,796,178
Put/Call ratio
10%
SEC-reported price per share
$60.65
Indexed holders
145
Value change
+$171,165,829
Number of buys
83
Open additional details 1 more signal available
Number of sells
54
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,073,952

Security key

457730109

Report period

Q2 2019

Indexed institutions

145

Top holders

10

Ownership snapshot

Top reported holders of INSP - Inspire Medical Systems, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Mar 2019
13F Highest disclosed value: $83,523,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $83.52M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ORBIMED ADVISORS LLC $83.52M
MORGAN STANLEY $78.98M
WILLIAM BLAIR INVESTMENT MANAGEME... $62.24M
BlackRock Finance, Inc. $55.64M
LORD, ABBETT & CO. LLC $53.89M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$83,523,000
1,471,000 shares
— 31 Mar 2019
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$78,975,000
1,390,914 shares
— 31 Mar 2019
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$62,236,000
1,096,095 shares
— 31 Mar 2019
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$55,638,000
979,876 shares
— 31 Mar 2019
LORD, ABBETT & CO. LLC
13F
Company
13F
—
denominator unverified
$53,890,000
949,100 shares
— 31 Mar 2019
FRANKLIN TEMPLETON INC
13F
Company
13F
—
denominator unverified
$48,843,000
860,216 shares
— 31 Mar 2019
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
145
Shares
19,969,050
Indexed holders
145
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 indexed holders
143
Q2 2019 indexed holders
145
Indexed holder difference
2
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 value Q2 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .